Massive newborn brain study launches in china
NCT ID NCT02544100
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aims to create a large database of medical information and biological samples from 2,000 newborns with brain conditions like encephalopathy. Researchers will collect blood, urine, and spinal fluid samples, along with genetic data, to better understand and monitor brain injury. The goal is to use this big data to predict brain damage and guide treatment in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to monitor and predict brain injury in newborns, and provide a rich data resource for future research.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data and samples, so it won't directly help participants. Results may take years to impact care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children Hospital of Fudan University
RECRUITINGShanghai, Shanghai Municipality, 201102, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI camera watches newborns' brains—no wires, no touch
- Baby eye exams may reveal hidden brain injury
- New sensor reveals how newborn brains adapt after birth
- New Light-Based monitor could help protect newborn brains
- New study maps normal heart function in newborns
- New sensor could spare sick newborns from painful blood tests